395 filings
Page 7 of 20
CORRESP
bz5ssnj zp
3 Jan 20
Correspondence with SEC
12:00am
UPLOAD
c7mi qgg8eh2e6e3es9
19 Dec 19
Letter from SEC
12:00am
8-K
6eahttiv3
18 Dec 19
Departure of Directors or Certain Officers
4:23pm
8-K
kkys5whx5p50q7 x9wj6
4 Dec 19
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
8:44am
8-K
othee
29 Oct 19
Entry into a Material Definitive Agreement
12:00am
8-K
b1zwsziv
10 Oct 19
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
4:01pm
8-K
tdp sl7eg
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
cau8c224
23 Aug 19
Departure of Directors or Certain Officers
4:02pm
8-K
oop6 8k6t9l
11 Jul 19
Changes in Registrant's Certifying Accountant
4:01pm
8-K
sm8bcv8yltw yf
10 Jul 19
Ampio Appoints Dan Stokely as the Company’s new Chief Financial Officer
4:02pm
8-K
hybd1go
19 Jun 19
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering
4:01pm
8-K
v1e i8kbuhfuejmlb
17 Jun 19
Ampio Pharmaceuticals Announces Pricing of Public Offering
9:23am
424B5
jnjo372ev7czm
17 Jun 19
Prospectus supplement for primary offering
8:21am
424B5
e40 4kjcr
17 Jun 19
Prospectus supplement for primary offering
6:04am
424B5
d4sote781iiun5tm
17 Jun 19
Prospectus supplement for primary offering
12:00am
8-K
oddmyj4
14 Jun 19
Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
4:02pm